Similarly to our present investigation, Broermann, Schmid [25] discovered that anti-fibrotic effects caused by the PDE5 inhibitor are represented by differently expressed miRNAs in the liver and reduce CCL4-induced chronic liver failure in rats. The gene discussed is CCL4; the disease is chronic liver failure.